Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple video and kit program help kids take their transplant meds?

NCT ID NCT07718204

Disease control Sponsor: Nationwide Children's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests a program called MedMemos for families of children who have had a bone marrow transplant. The program includes four sessions with educational videos and a kit to help manage medications. Researchers want to see if families find it useful and if it helps them take their medicines as prescribed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MedMemos, a 4-session behavioral intervention with videos and a medication management kit
What this could lead to
If it works, MedMemos could become a standard tool to help families manage complex medication schedules after a bone marrow transplant, improving health outcomes.
What could go wrong
This is a small, early-stage trial focused on feasibility and acceptability, not yet on proving effectiveness. The results may not apply to all families or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT) * Child is 0-12 years of age * At the time of recruitment child is still in the hospital for PAHCT * Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate * Child is prescribed an oral medication regimen at discharge Exclusion Criteria: * Caregiver does not speak English, Spanish, or Arabic * Caregiver is not available to provide written permission for the child's participation * EMR or medical team report of the caregiver's cognitive status precludes completion of questionnaires * The child's medical status or condition precludes completion of the study questionnaires as determined by the physician or caregiver * Caregiver is unwilling to store medication in an electronic monitor

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hematopoietic cell transplant are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bone Marrow Failure Disorders Infections Medication Adherence neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hematopoietic cell transplant

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.